Rajan Senguttuvan
Pediatric Endocrinology · Corpus Christi, TXNPI 1740543396
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 170 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $974 and has fallen 96.7% since, to $33 in 2025.
Across 170 payments — averaging $20.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$690
- AbbVie$501
- Ascendis Pharma Endocrinology Inc$440
- Medtronic$314
- Insulet Corporation$187
- Dexcom, Inc.$163
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,560100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 40 | $690 |
| AbbVie | 29 | $501 |
| Ascendis Pharma Endocrinology Inc | 15 | $440 |
| Medtronic(2 entities) | 5 | $314 |
| Insulet Corporation | 11 | $187 |
| Dexcom, Inc. | 9 | $163 |
| Abbott | 7 | $142 |
| Tandem Diabetes Care, Inc. | 6 | $137 |
| Biomarin Pharmaceutical Inc. | 3 | $125 |
| Tolmar Pharmaceuticals, Inc. | 6 | $123 |
| Pfizer | 7 | $116 |
| AstraZeneca | 4 | $104 |
| Tolmar, Inc. | 4 | $82 |
| Xeris Pharmaceuticals, Inc. | 4 | $81 |
| Eton Pharmaceuticals, Inc. | 3 | $60 |
| Ferring Pharmaceuticals Inc. | 4 | $56 |
| Lilly USA, LLC | 3 | $54 |
| Kyowa Kirin, Inc. | 2 | $46 |
| Ipsen Biopharmaceuticals, Inc | 2 | $30 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Rhythm Pharmaceuticals, Inc. | 1 | $21 |
| Arbor Pharmaceuticals, Inc. | 1 | $20 |
| Companion Medical, Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Vistapharm, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Minimed 670G System$153
- SKYTROFA$109
How this compares
$3,560 in reported general payments places this provider in the 75th percentile of 120 pediatric endocrinology providers in Texas.
Other pediatric endocrinology in Corpus Christi
- Ana PaezCorpus Christi$4K
- Jacqueline Reyes DiazCorpus Christi$3K
- Erica Maris WeeCorpus Christi$2K
- Beatriz BlinovCorpus Christi$2K
- Jose Gamez-GodoyEdinburg$207K
- Virginia AraizaHouston$151K
- Daniel DesalvoHouston$133K
- Amy BurtonPlano$130K
- Susan NunezAustin$91K
- Hector GranadosEl Paso$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.